6 Billionaires Bought Small-Caps. Here Are 3 Names Worth Watching.
There’s a reason investors track billionaire portfolios.
And when multiple well-known managers start circling the same small-cap names, it can be a useful signal — not because billionaires are magicians, but because they tend to have better access, deeper research benches, and more patience than the average investor.
That doesn’t mean you should blindly copy every 13F filing.
It does mean you should pay attention when several smart operators end up in the same neighborhood.
Because that usually tells you one of three things: the market is missing a catalyst, mispricing a business, or ignoring a niche that could get a lot more interesting in a hurry.
Some businesses are exciting.
Some businesses quietly make money selling the stuff other businesses cannot function without.
Company: SiteOne Landscape Supply, Inc. (SYM: SITE)
SiteOne says it offers more than 100,000 SKUs across irrigation supplies, fertilizers, control products, lighting, nursery goods, hardscapes, and other landscape inputs through a broad North American branch network. In plain English: this is a picks-and-shovels company for landscaping contractors.
It isn’t.
Because sleepy businesses can be beautiful when they dominate a fragmented niche.
SiteOne reported fourth-quarter and full-year 2025 results in February and said it delivered positive organic daily sales growth in the fourth quarter while continuing adjusted EBITDA margin expansion, even in what management called a persistently unfavorable operating environment. That’s the kind of sentence value investors like to underline. Not because it’s sexy. Because it suggests resilience when conditions are still tough.
The stock closed at about $131.75 on March 6, 2026, giving it a market cap of roughly $5.76 billion. That still puts it in the smaller-company bucket relative to the mega-cap universe most investors hide in.
That’s usually where the good setups live.
Medline says it is the largest provider of medical-surgical products and supply chain solutions serving all points of care. The company operates through two segments — Medline Brand and That matters because this is not some pre-revenue healthcare moonshot.
As of March 6, 2026, the stock was trading around $43.75.
And it tells you the market has not treated this like a sleepy supply distributor since the IPO.
The operating numbers help explain why. In its fourth-quarter and full-year 2025 results, reported on February 25, 2026, Medline said it delivered strong fourth-quarter results and finished 2025 with That’s not a tiny niche story.
That’s a company still gaining business at scale.
That gives the story weight.
The company could seek a valuation above 1.75 trillion dollars.
That would make SpaceX larger than Meta and even Musk's own Tesla.
The IPO could raise as much as 50 billion dollars, which is nearly double the current record set by Saudi Aramco in 2019.
The cash-register play: Gildan looks boring until you notice the earnings power
Then there’s the name almost nobody brags about owning at a dinner party.
Company: Gildan Activewear Inc. (SYM: GIL)
Vertically integrated basic-apparel manufacturer with strong brands and cash-flow potential.
Gildan manufactures and sells activewear, underwear, hosiery, and related basics across North America, Europe, Asia-Pacific, and Latin America. The company says it operates as one of the world’s largest vertically integrated apparel manufacturers, giving it control over a large piece of its supply chain.
Which is exactly why it gets interesting.
On February 26, 2026, Gildan reported record fourth-quarter revenue for 2025 and initiated its 2026 guidance. That tells you management sees continued strength in the business and enough visibility to talk confidently about the year ahead.
This is where a lot of investors get tripped up.
It doesn’t.
Sometimes the better setup is a company making money on goods people buy without thinking twice. If management executes well, if margins hold up, and if demand stays steady, the stock does not need a science-fiction narrative to work.
That’s what Gildan has.
So what’s the bottom line?
slow, steady operating-business setup, SiteOne is the cleanest fit.
If you want the boring-business-can-still-win setup, Gildan is the easiest name to underestimate.
That’s usually where the edge lives.
Not in the loudest story.
In the one the market has not fully priced yet.
Paradigm Press
Public Law 63-43: Trump’s Secret Weapon to Win the Midterms?
But the 112-year-old little-known law you see below…
Click here to see the details…
Because Public Law 63-43 could also have a huge impact on your wealth in 2026…